Morten W Fagerland

Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant Recipients.

K. Karason, K. Broch, H. Eiskjær, 2024, JACC. Heart failure.